News

Aphios Corporation recently announced that United States Patent 9,034,347 has been granted to the company’s lead compound to treat neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease, Hutchinson Disease and Down’s syndrome. Alzheimer’s disease, Parkinson’s disease, Hutchinson’s Disease, Kuru Creutzfeldt-Jakob disease, further spongiform encephalopathies and all neurodegenerative diseases in general remain enormous health problems with numerous…

Findings from a recent study published in the journal Neurology revealed that individuals with more skilled jobs may live longer after developing frontotemporal dementia in comparison with individuals with less skilled jobs. Frontotemporal dementia is a condition that mainly affects individuals aged under 65 years and causes…

Findings from a recent study conducted by a team of researchers in China indicate that certain conditions of exposure of extremely low frequency electromagnetic fields could delay the development of Alzheimer’s’ Disease (AD) in rats. The study was published in the journal PLOS One. Extremely low frequency…

The existence of specific and reliable biomarkers for Alzheimer’s disease are crucial to identifying individuals to enroll in clinical trials so that drugs can be tested and diseases can be detected as soon as possible. Facilitating clinical trial enrollment allows studies that are researching and developing therapies that stop or slow Alzheimer’s disease progression…

A new study recently published in the journal Human Brain Mapping revealed that the shape of the hippocampus might be more telling than the size of the hippocampus in terms of memory and cognitive function. The study is entitled “Hippocampal (subfield) volume and shape…

Findings from a study recently conducted by neuropsychologist Christiane Möller as part of her doctoral work showed that patients with Alzheimer’s disease as well as behavioral variant frontotemporal dementia have large differences in their brains’ white matter. For her research, which is funded by the NWO’s National Initiative Brain & Cognition,…

Researchers from Bar-Ilan University and the University of Edinburgh were able to characterize for the first time changes in early-stage Alzheimer’s disease that occur inside individual brains. Results from the study published in the journal Neuron suggest that Alzheimer’s-affected cells result in a reduction of electrical activity throughout…

The non-governmental organization American Association of Retired Persons (AARP) will host over 40 screenings of the Oscar-winning drama “Still Alice” in collaboration with Sony Pictures Home Entertainment. The screenings will take place nationwide between May and June and are coinciding with the release of the film to DVD and Blu-Ray on…

In a new study entitled “Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease,” researchers established the molecular structure of a key form of amyloid-β (Aβ) protein, Aβ42. This finding allows researchers to understand how Aβ42 accumulates in plaque aggregates in the brain of…

In a recent study published in the journal Alzheimer’s Research & Therapy, a team of researchers from the University of British Columbia discovered that a novel drug for epilepsy might lead to a potential a treatment for Alzheimer’s disease. The study results support the theory that…